Huntington’s Disease Clinical Trials Corner: February 2018

J Huntingtons Dis. 2018;7(1):89-98. doi: 10.3233/JHD-189001.


In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Clinical Trials as Topic*
  • Humans
  • Huntington Disease / drug therapy*
  • Registries / statistics & numerical data
  • Tetrabenazine / analogs & derivatives*
  • Tetrabenazine / therapeutic use
  • Treatment Outcome


  • deutetrabenazine
  • Tetrabenazine

Associated data